Permixon is a saw palmetto berry extract. The key important ingredient is an n-hexane lipidosterolic agent. Particular attention has been focused on the potential for saw palmetto to treat benign prostatic hyperplasia. That is prostate enlargement but not due to cancerous cells. The prostate is particularly sensitive and responsive to estrogen and testosterone hormone concentrations.
Several reports indicate saw palmetto is effective in treating benign prostatic hyperplasia.
Animal models show that Permixon will inhibit prostate gland enlargement when rats are given estrogens and testosterone. Other animal studies reveal that the Permixon is being preferentially taken up and retained in the prostate gland. Human treatment using saw palmetto is much more widely practiced in Treatment of human prostatic hyperplasia typically involves oral ingestion of 160mg saw palmetto extract twice a day. Saw palmetto seems to work locally at the actual site of hormone binding to receptors on cells. It apparently stops or at least reduces the receptor binding of androgens.